Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02164630 · ClinicalTrials.gov registry record · NA
Optimizing Resilience In Orofacial Pain and Nociception
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT02164630: Completed NA study, sponsored by University of Florida.
NCT02164630 is a NA study that has completed, run by University of Florida. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02164630, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of a hope-based intervention on clinical and experimental pain in individuals with temporomandibular disorder (TMD). To examine the effectiveness of this intervention, a two-arm randomized trial will be conducted with 50 individuals, between the ages of 18 and 65, who have TMD.
Primary Outcome
The Adult State Hope Scale is a 6-item inventory used to assess goal-directed thinking at a given moment in time.
Interventions
- BEHAVIORAL Hope Therapy
- OTHER Pain Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02164630 record still lists
NCT02164630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Hope Therapy is the first listed.
NCT02164630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02164630 about?
NCT02164630 is a clinical study titled "Optimizing Resilience In Orofacial Pain and Nociception". The purpose of this study is to examine the effects of a hope-based intervention on clinical and experimental pain in individuals with temporomandibular disorder (TMD). To examine the effectiveness of this intervention, a two-arm randomized trial will be conducted with 50 individuals, between the ag...
What is the current status of trial NCT02164630?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2014-09. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02164630?
The interventions under investigation include: Hope Therapy (BEHAVIORAL), Pain Education (OTHER).
Who is sponsoring clinical trial NCT02164630?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02164630's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia